全身炎症反应综合征(SIRS)

全身炎症反应综合征(SIRS)的相关文献在2003年到2022年内共计113篇,主要集中在内科学、外科学、中国医学 等领域,其中期刊论文110篇、专利文献271543篇;相关期刊66种,包括中国急救医学、中华肝胆外科杂志、中华烧伤与创面修复杂志等; 全身炎症反应综合征(SIRS)的相关文献由345位作者贡献,包括F·微纳特、G·蒙那尔特、中华医学会儿科学分会急救学组等。

全身炎症反应综合征(SIRS)—发文量

期刊论文>

论文:110 占比:0.04%

专利文献>

论文:271543 占比:99.96%

总计:271653篇

全身炎症反应综合征(SIRS)—发文趋势图

全身炎症反应综合征(SIRS)

-研究学者

  • F·微纳特
  • G·蒙那尔特
  • 中华医学会儿科学分会急救学组
  • 陈贤楠
  • A·勒帕珀
  • 中华医学会急诊学分会儿科组
  • 任一鸣
  • 何志承
  • 刁翔文
  • 刘凌
  • 期刊论文
  • 专利文献

搜索

排序:

年份

    • 李钰昕; 孙璐; 刘迪; 疏欣杨; 张洪春
    • 摘要: 目的系统评价血必净注射液联合血液净化治疗全身炎症反应综合征(SIRS)的疗效及安全性,为SIRS提供临床用药循证参考。方法计算机检索WanFang、VIP、CNKI、CBM、PubMed、Embase及Cochrane数据库,收集血必净注射液联合血液净化治疗SIRS的随机对照试验,检索时间为数据库建立至2021年12月22日。进行纳入及排除标准的文献筛选,根据Cochrane国际协作网规程,进行质量控评和偏倚评估,Meta分析运用Revman 5.3进行。结果共检索275篇文献,最终纳入29项临床随机对照试验,共计2152例患者。荟萃分析显示,血必净注射液可提高血液净化疗法的总有效率[加权均数差(WMD)=0.24,95%可信区间(CI)(0.18,0.30),P<0.00001],缩短患者ICU住院时间[WMD=-3.74,95%CI(-5.74,-1.59),P=0.0002],降低急性生理学与慢性健康状况评估系统Ⅱ(APACHEⅡ)评分[WMD=-4.49,95%CI(-5.42,-3.55),P≤0.00001],有效改善肿瘤坏死因子-α(TNF-α)[WMD=-28.28,95%CI(-33.88,-22.68),P≤0.00001]、白细胞介素-6(IL-6)[WMD=-37.44,95%CI(-52.10,-22.79),P≤0.00001]炎症因子水平,不增加不良反应[WMD=-55,95%CI(0.27,1.13),P=0.1]。结论血必净注射液可以提高血液净化疗法SIRS患者的疗效,抑制炎症反应,且不增加不良反应。这一结论也为新型冠状病毒肺炎继发SIRS的治疗提供一定的依据。
    • 梁鑫; 戚梦芸; 张科荣; 范波; 满凤
    • 摘要: 妊娠是女性的一段特殊生理时期,此阶段孕妇免疫受到抑制,若合并感染易发展为重症.产科重症感染是导致孕产妇死亡的四大原因之一,主要表现为脓毒血症,进而发展成感染性休克、多器官功能障碍或衰竭,最终导致死亡.针对产科重症感染,需重视多重耐药菌,及时去除病灶,同时强调多学科协作诊疗模式(MDT)的重要性.
    • 李建国; 穆洪; 郭伟; 单凯; 徐玢; 杨铁城; 董小燕; 陈必耀; 杜涵洋; 郝峰
    • 摘要: 目的 评价乌司他丁治疗急性重症脑出血所致全身炎症反应综合征(systemic inflammatory response syndrome,SIRS)患者的临床疗效、安全性及其作用机制.方法 将急性重症脑出血所致SIRS,且未行手术治疗的100例患者随机分为治疗组和对照组各50例,两组均给予相同的常规治疗,治疗组加用乌司他丁,对照组给予等量生理盐水作为对照,治疗前后测定患者血清肿瘤坏死因子-α(TNF-α)、白细胞介素(IL)-1、IL-6.结果 乌司他丁治疗组患者治疗第1、7天的血清TNF-d[(9.65±3.72) pg/mL,(6.82±4.64) pg/mL]、IL-1[(5.33±2.36) pg/mL,(3.62±2.56) pg/mL]、IL-6[(11.65±5.67)pg/mL,(8.52±4.85) pg/mL]均明显低于对照组(P<0.05);治疗组患者治疗后7、28 d NIHSS评分[(14.5±5.2)分,(12.1±5.4)分]及MODS的发生率(40.8%,66.6%)均明显低于对照组(P<0.05).结论 乌司他丁能够有效降低重症脑出血所致SIRS患者的血清TNF-α、IL-1、IL-6水平,从而降低多器官功能障碍综合征(MODS)的发生率,改善预后.%Objective To evaluate the clinical efficacy,safety and mechanism of action of ulinastatin for the treatment of systemic inflammatory response syndrome (SIRS) associated with acute severe cerebral hemorrhage.Methods The patients with acute severe cerebral hemorrhage-associated SIRS were randomized into the treatment group and control group to receive standard of care.Ulinastatin was administered as add-on in the treatment group and the same volume of physiological saline was administered as control in the control group.Serum TNF-α,IL-1 and IL-6 levels were measured before and after treatment.Results One hundred patients with acute severe cerebral hemorrhage-associated SIRS were randomized into the treatment group (n =50) and control group (n =50).No significant differences in population data were seen between both groups.At Day 1 and Day 7,the ulinastatin treatment group had statistically significantly lower serum levels than the control group [(9.65 ± 3.72) pg/mL,(6.82 ± 4.64) pg/mL],IL-1 [(5.33 ± 2.36) pg/mL,(3.62 ± 2.56) pg/mL] and IL-6[(11.65 ± 5.67) pg/mL,(8.52 ± 4.85) pg/mL] (P < 0.05).At Day 7 and Day 28,the treatment group had a statistically significantly lower NIHSS score and incidence of multiple organ dysfunction syndrome (MODS) than the control group [(14.5 ± 5.2) scores,(12.1 ± 5.4) scores,(40.8%,66.6%)],(P < 0.05).Conclusion Ulinastatin effectively reduces the serum TNF-α,IL-1 and IL-6 levels in patients with acute severe cerebral hemorrhage-associated SIRS,thus reducing the incidence of MODS and improving prognosis.
    • 李建华; 任小莉; 田培刚; 程青虹
    • 摘要: 目的 探讨强化胰岛素治疗下不同目标血糖管理对脓毒症患者凝血机制的影响.方法 研究设计为随机的、前瞻性的、双盲的、 临床干预的对照研究.将2015-10~2016-09新疆石河子大学医学院第一附属医院重症医学科(ICU)90例脓毒症患者按随机数字表法分为三组,每组各30例.A组:控制血糖4.4~6.1 mmol/L,B组:控制血糖6.1~8.3 mmol/L,C组:控制血糖8.3~10.0 mmol/L.所有患者在治疗前(T0)及治疗后1 d、3 d、7 d(T1、T3、T7)不同时间点分别监测凝血功能指标及相关预后指标,同时记录各组患者性别、年龄、APACHE Ⅱ评分、SOFA 评分、白细胞计数(WBC)、治疗前血糖水平和低血糖发生率.结果 三组患者治疗前后凝血指标比较、治疗前(T0)三组患者凝血指标比较差异均无统计学意义(P>0.05),治疗后A 组凝血指标与B、C组比较差异有统计学意义(P0.05).A组D-二聚体治疗后7 d与治疗前比较差异有统计学意义(P0.05).结论 将脓毒症患者血糖控制于4.4~6.1 mmol/L,可显著改善其凝血功能,提高28 d生存率,改善预后.%Objective To investigate the effect of different blood glucose management under intensive insulin therapy on blood coagulation in patients with sepsis.Methods A randomized, prospective, double-blind, clinical intervention study was designed.In the First Affiliated Hospital of Shihezi University from October 2015 to September 2016, 90 cases of sepsis patients were randomly divided into 3 groups according to the random number table method.The 30 cases were randomly divided into groups.Group A: control blood sugar 4.4~6.1 mmol/L, group B: control blood sugar 6.1~8.3 mmol/L, group C: control blood sugar 8.3~10.0 mmol/L.All patients after treatment in 1, 3, 7 days at different time points were monitored indexes of coagulation function, simultaneous recording of groups with gender, age, APACHE Ⅱ score, white blood cell count (WBC), treatment level of blood glucose, hypoglycemia incidence and the ICU hospitalization days, 28 days mortality.Results Three groups of patients before (T0) and after treatment of coagulation indicators, compared with the three groups before treatment, the difference was not statistically significant (P>0.05).There was significant difference between the group A and the group B, C, the difference was statistically significant (P0.05).Seven days after treatment, D-dimer level in group A was significantly decreased compared with that before treatment (P0.05).Conclusion In patients with sepsis, blood sugar control within 4.4~6.1 mmol/L, can significantly improve the coagulation function, the survival rate of 28 d and the prognosis.
    • 翁湘涛; 曹家栋; 何君伟; 王树声; 向松涛; 古炽明; 甘澍
    • 摘要: 目的 探讨国内经皮肾镜取石术(PCNL)后发生全身炎症反应综合征(SIRS)的危险因素.方法 计算机检索国内有关PCNL术后发生SIRS的相关研究,时间截止至2016年10月,采用RevMan 5.3进行Meta分析.结果 共纳入18个研究,5323例患者,Meta分析结果显示:①单因素分析结果:肾功能不全[O(R)=2.78,95%CI(1.96,3.95),P=0.000]、术前尿培养细菌阳性[O(R)=3.41,95%CI(1.89,6.15),P=0.000]、术前尿常规白细胞异常[O(R)=3.78,95%CI(3.02,4.72),P=0.000]、糖尿病[O(R)=2.14,95%CI(1.33,3.45),P=0.002]、结石细菌培养阳性[O(R)=5.14,95%CI(2.46,10.73),P=0.000]和手术时间≥120 min[O(R)=2.31,95%CI(1.40,3.82),P=0.001]是PCNL术后发生SIRS的危险因素;②多因素分析显示:术前尿培养细菌阳性[O(R)=6.83,95%CI(2.82,16.57),P=0.000]、术前尿常规白细胞异常[O(R)=5.43,95%CI(3.51,8.41),P=0.000]、糖尿病[O(R)=2.85,95%CI(1.45,5.58),P=0.002]、结石细菌培养阳性[O(R)=4.30,95%CI(1.30,14.21),P=0.020]和手术时间≥120 min[O(R)=2.72,95%CI(1.62,4.59),P=0.000]是PCNL术后发生SIRS的独立危险因素.结论 糖尿病、术前尿培养细菌阳性、术前尿常规白细胞异常、结石细菌培养阳性和手术时间是PCNL术后发生SIRS的独立危险因素,受纳入研究数量和质量影响,需开展更多高质量研究证实上述结论.%Objective To explore the risk factors of systemic inflammatory response syndrome crisis (SIRS) after percutaneous nephrolithotomy (PCNL) in China. Methods Databases of CNKI, CBM, WanFan and VIP were searched to retrieve studies about systemic inflammatory response syndrome after percutaneous nephrolithotomy to October, 2016. Results 18 studies involving 5,323 patients were included. The results of meta-analysis showed that:a) univariate analysis indicated that renal insufficiency [O(R) =2.78, 95%CI (1.96 to 3.95), P = 0.000], preoperative positive urine culture [O(R) = 3.41, 95%CI (1.89 to 6.15), P = 0.000], preoperative routine urine leucocyte positive [O(R) = 3.78, 95%CI (3.02 to 4.72), P = 0.000], diabetes mellitus [O(R) = 2.14, 95%CI (1.33 to 3.45), P = 0.002], pelvic positive urine culture [O(R)= 5.14, 95%CI (2.46 to 10.73), P = 0.000] and operation time ≥120 min [O(R) = 2.31, 95%CI (1.40 to 3.82), P = 0.001] were the risk factors of SIRS; b) multivariate analysis showed that, preoperative positive urine culture [O(R) = 6.83, 95%CI (2.82 to 16.57), P = 0.000], preoperative routine urine leucocyte positive [O(R) = 5.43, 95%CI (3.51 to 8.41), P = 0.000], diabetes mellitus [O(R) = 2.85, 95%CI (1.45 to 5.58), P = 0.002], pelvic positive urine culture [O(R) = 4.30, 95%CI (1.30 to 14.21), P = 0.020] and operation time ≥120 min [O(R) = 2.72, 95%CI (1.62 to 4.59), P = 0.000] were the independent risk factors of MCAT. Conclusion The independent risk factors of SIRS for patients after PCNL are diabetes mellitus, preoperative positive urine culture, preoperative routine urine leucocyte positive, pelvic positive urine culture and operation time. However, due to the quantity and low quality of the included literature, the conclusion needs the support from high quality studies.
    • 杨家来; 徐俊
    • 摘要: 脓毒症是重症监护室常见的危重症,总体预后较差,病死率较高.脓毒症发生机制的研究对脓毒症的预防和治疗具有重要的临床意义.近年来,维生素D(Vit D)与脓毒症的关系逐渐受到重视,研究发现,Vit D在脓毒症全身炎症反应综合征(SIRS)和机体对病原菌免疫防御反应等机制中起重要作用.本文就近期相关研究进展做一综述.
    • 李焕根; 陈伟文; 郑文博
    • 摘要: 目的 探讨连续性肾脏替代治疗(continuous renal replacement therapy,CRRT)对全身炎症反应综合征(systemic inflammatory response syndrome,SIRS)合并毛细血管渗漏综合征(capillary leak syndrome,CLS)患者血流动力学指标、APACHEⅡ评分及住院时间的影响.方法 选取2013-02~2015-02我院收治的82例SIRS合并CLS患者,40例行CRRT的患者为试验组,42例因家庭经济原因未接受CRRT方案的患者为对照组,对照组患者给予常规综合治疗,试验组患者在此基础上实施CRRT治疗,比较两组患者治疗前及治疗后48 h中心静脉压(central venous pressure,CVP)、平均动脉压(mean arterial pressure,MAP)、氧合指数(oxygenation index,OI)、心率(heart rate,HR)、尿量、血管外肺水(extravascular lung water,EVLW)、肺血管通透性指数(pulmonary vaseular permeability index,PVPI)、白细胞计数(white blood cell count,WBC)、C反应蛋白(c-reactive protein,CRP)水平变化情况以及治疗后两组患者APACHEⅡ评分及住院时间.结果 试验组患者治疗后MAP、0I及尿量均明显高于对照组[(92.16± 11.01) mm Hg vs.(84.15± 11.68) mm Hg、(231.06±33.68) mm Hg vs.(189.48±31.97) mm Hg、(73.11± 12.67)mL/h vs.(52.17± 11.06) mL/h],差异有统计学意义(P<0.05);试验组患者治疗后EVLW、PVPI均明显低于对照组[(7.09±0.58) mL/kgVS.(8.72±0.52)mL/kg、(2.27±0.82)%vs.(3.85±0.80)%],差异有统计学意义(P<0.05);试验组患者治疗后WBC、CRP均明显低于对照组[(10.59±3.15)× 109/L vs.(14.81±3.56)×109/L、(70.15±30.08)mg/L vs.(100.26±45.51) mg/L],差异有统计学意义(P<0.05);试验组患者治疗后APACHEⅡ评分和住院时间均明显低于对照组[(10.01±3.97)分vs.13.12±5.11)分、(85.97±20.08)h vs.(135.16±25.17)h],差异有统计学意义(P<0.05).结论 CRRT可有效改善SIRS合并CLS患者血流动力学指标和炎症指标,改善微循环,促进排尿,降低毛细血管通透性,能够提高预后效果.
    • 马镇; 苏彧
    • 摘要: 目的 探讨早期腹腔灌洗对重症急性胰腺炎(SAP)患者的临床疗效及对外周血辅助性T细胞17(Th17)/调节性T细胞(Treg)平衡的影响,旨在为SAP的临床治疗提供参考.方法 选择SAP患者132例,随机分为A组和B组,每组各66例;另于同期匹配性选取健康志愿者60例,设为对照组.A组早期采用综合治疗措施,B组在此基础上予以腹腔置管灌洗引流术.检测对照组体检当日及A、B组入院第1、4、7天外周血Th17、Treg细胞比例,计算Th 17/Treg比值;比较A、B组入院第1、4、7天血淀粉酶、C反应蛋白(CRP)水平、APACHEⅡ评分.记录A、B组72 h内发生全身炎症反应综合征(SIRS)例数并记录SIRS持续时间、多器官功能障碍综合征(MODS)例数.结果 A、B组入院第1天外周血Th17、Treg细胞百分比及Th 17/Treg比值均高于对照组体检当日各指标水平(t=3.92~ 7.39,P<0.05或P<0.01).治疗后,除B组第7天Treg百分比、Th 17/Treg比值外,A、B组外周血Th17、Th 17/Treg比值及APACHEⅡ评分、血淀粉酶、CRP水平均依次降低(t=3.40~ 7.17,P<0.05或P<0.01),而Treg细胞百分比升高(t=3.56 ~ 6.25,P<0.05或P<0.01),且B组外周血Th17、Treg细胞百分比及Th 17/Treg比值及APACHEⅡ评分、血淀粉酶、CRP水平均低于A组(t=3.55~7.02,P<0.05或P<0.01).B组72 h内SIRS、MODS发生率均低于A组(x2=4.13、4.59,P< 0.05),B组SIRS持续时间及住院时间均少于A组(t=5.45、4.29,P<0.05).Spearman相关分析显示,SAP患者外周血Th 17/Treg比值与CRP水平呈显著正相关(r=0.785,P<0.05).结论 早期腹腔灌洗通过清除腹腔内的炎性介质,减轻SAP患者的早期急性炎症反应,促进Th17/Treg细胞平衡的恢复,阻断或降低SIRS的发展,降低MODS的发生率,减少住院时间,对SAP的临床治疗具有一定的指导和借鉴意义.
    • 倪健强; 赵红如; 何萍; 段晓宇; 王辉; 徐敏; 方琪; 董万利
    • 摘要: Objective To investigate risk factors and prognosis of systemic inflammatory re⁃sponse syndrome(SIRS)caused by posterior circulation cerebral infarction(PCI). Methods Clinical data of 108 acute PCI patients were analyzed retrospectively. According to diagnosis criteria of SIRS, all patients were divided into two groups: with SIRS group and without SIRS group within the 21 days after onset. The clinic records and laboratory data were analyzed by logistic regression to find potential risk factors of SIRS caused by PCI and contributors of prognosis. Results Forty- nine PCI patients had SIRS within the 21 days after onset. Four factors including history of diabetes, brainstem injury, NIHSS, dysphagia had statistics differences(P<0.05)by univariate analysis. NIHSS(OR=1.132, 95% CI 1.011~1.269, P=0.032), brainstem injury(OR=4.044, 95%CI 1.129~14.494, P=0.032)were the in⁃dependent risk factors for SIRS caused by PCI proved by multivariate analysis. NIHSS(OR=1.552, 95%CI 1.060~2.272, P=0.024)influenced the prognosis of PCI patients with SIRS. Conclusion Risk fac⁃tors associated with SIRS caused by PCI are degree of neurological deficits and injury of brainstem. And degree of neurological deficits affects the prognosis of PCI patients with SIRS.%目的:探讨影响后循环脑梗死诱发全身炎症反应综合征(SIRS)的危险因素及对预后的影响。方法回顾性分析108例后循环脑梗死患者临床资料。根据SIRS的诊断标准,比较发病后21 d内合并SIRS与无SIRS患者之间的差异,对可能影响后循环脑梗死诱发SIRS的若干因素进行多因素回归分析。并进一步通过 Logistic 回归分析影响合并 SIRS 的后循环脑梗死患者预后的危险因素。结果49例后循环脑梗死患者在发病后21 d内出现SIRS。单因素分析显示,糖尿病史、脑干受累、入院时 NIHSS 评分和吞咽困难4个因素有统计学意义(P<0.05),而多因素分析显示,入院时 NIHSS 评分(OR=1.132,95%CI 1.011~1.269,P=0.032)、脑干受累(OR=4.044,95%CI 1.129~14.494,P=0.032)为影响后循环脑梗死诱发 SIRS 的独立危险因素。其中入院时NIHSS评分(OR=1.552,95%CI 1.060~2.272,P=0.024)是后循环脑梗死合并SIRS预后不良的独立危险因素。结论入院时神经功能缺损程度、病灶是否累及脑干是后循环脑梗死患者发生SIRS的独立危险因素,而神经功能缺损程度影响了合并SIRS后循环脑梗死患者的预后。
    • 陈建南; 丁毅鹏
    • 摘要: 目的 探讨血浆脂联素、肿瘤坏死因子-α(TNF-α)和白细胞介素-6(IL-6)在脓毒症和全身炎症反应综合征(SIRS)鉴别诊断中的临床意义.方法 选取SIRS患者26例,脓毒症患者210例(一般脓毒症组83例、严重脓毒症组68例及感染性休克组59例),健康对照20例.比较各组患者血浆脂联素、TNF-α和IL-6差异.结果 脓毒症各组血浆脂联素均显著低于SIRS组(P<0.05).脓毒症各组血浆TNF-α均显著高于SIRS组(P<0.05).脓毒症各组血浆IL-6均显著高于SIRS组(P<0.05).结论 联合检测血浆脂联素、TNF-α和IL-6对脓毒症鉴别诊断具有一定指导意义.
  • 查看更多

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号